TBIO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:03):

Stats
Tagesvolumen	23 606.00
Durchschnittsvolumen	759 938
Marktkapitalisierung	10.08M
EPS	$0 ( 2024-04-02 )
Nächstes Ertragsdatum	( $-0.140 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.200
ATR14	$0.00300 (0.90%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Esser Eric Eugene	Buy	200 000	Stock Option (right to buy)
2024-04-17	Esser Eric Eugene	Buy	100 000	Common Stock
2023-06-22	Nelson Todd Robert	Buy	385 500	Stock Option (right to buy)
2023-06-22	Nelson Todd Robert	Buy	47 700	Common Stock
2024-03-01	Nelson Todd Robert	Sell	4 756	Common Stock

INSIDER POWER
95.80
Last 89 transactions
Buy: 85 527 522 \| Sell: 75 379 307

Volumen Korrelation

Lang: 0.04 (neutral)

Kurz: 0.81 (strong)

Signal:(60.904) Same movement expected

Translate Bio Inc Korrelation

10 Am meisten positiv korreliert
GMII	0.905
AFYA	0.889
EAR	0.88
TRMK	0.878
XPDI	0.874
WASH	0.872
ATSG	0.864
ALHC	0.863
GOOD	0.862
CSSEP	0.86

10 Am meisten negativ korreliert
DRNA	-0.948
SUMO	-0.941
OCSL	-0.925
CMPI	-0.908
ALBO	-0.906
MIGI	-0.895
IMAQ	-0.893
TCBC	-0.892
ZIONP	-0.89
XM	-0.89

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Translate Bio Inc Korrelation - Währung/Rohstoff

0.19
( neutral )

-0.03
( neutral )

0.00
( neutral )

-0.59
( weak negative )

Translate Bio Inc Finanzdaten

Annual	2023
Umsatz:	$27.51M
Bruttogewinn:	$12.85M (46.70 %)
EPS:	$-1.600

FY	2023
Umsatz:	$27.51M
Bruttogewinn:	$12.85M (46.70 %)
EPS:	$-1.600

FY	2022
Umsatz:	$27.44M
Bruttogewinn:	$15.60M (56.84 %)
EPS:	$-1.650

FY	2020
Umsatz:	$138.81M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.046

Financial Reports:

No articles found.

Translate Bio Inc

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.